ARCHIVES

In Brief: Bioassay Prime Contract Renewed For Four Years, $34.2 Million; Canellos Quits As Clinical Director

This article is from The Cancer Letter archive.

Vol. 01 No. 25 | June 20, 1975

Download PDF Visit The Full Archive

Related Articles

NCI Issues Alert On Stage 2/3 Rectal Cancer Therapy

March 22, 1991

High Cervical Cancer Rates Indicate Access Problems

August 26, 2005

Pfizer Begins Phase III Trial Of Sunitinib In NSCLC

September 28, 2007

Recombinant Protein C Cuts Risk Of Sepsis Death

February 22, 2002

In congress: Scientists Seek Closing NIH Office Of Alternative Medicine

July 11, 1997

Mayo’s Regional Program – Keys To Success Are Service, Communications

December 9, 1977